Nieuws en video's - EVOLENT HEALTH INC CLASS A

Evolent Announces Fourth Quarter and Full Year 2023 Results Full year revenue of $1,963.9 million, 45% growth over 2022 Net loss attributable to common shareholders of Evolent Health, Inc. of $(142.3) million Adjusted EBITDA of $194.7 million, 84% growth over 2022 2023 cash flow from operations of $142.6 million Provides initial outlook for 2024 in line with long-term targets PR Newswire WASHINGTON, Feb. 22, 2024 WASHINGTON , Feb. 22, 2024 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a...

Evolent Adds Russell Glass, Headspace CEO, to Board of Directors PR Newswire WASHINGTON, Feb. 14, 2024 WASHINGTON , Feb. 14, 2024 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable, today appointed Russell Glass to its Board of Directors. Glass has almost 25 years of experience as a successful technology and health care executive who...

Evolent to Release Fourth Quarter 2023 Financial Results on Thursday, February 22, 2024 PR Newswire WASHINGTON, Jan. 25, 2024 Company to Participate in Upcoming Investor Conferences WASHINGTON , Jan. 25, 2024 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable, today announced it will release its fourth quarter 2023 financial results on...

Evolent Health, Inc. Announces Pricing of $350.0 Million of Convertible Senior Notes Due 2029 to Pay Down Senior Term Loan PR Newswire WASHINGTON, Dec. 5, 2023 WASHINGTON , Dec. 5, 2023 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH) , a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable ("Evolent"), today announced the pricing of $350.0 million aggregate principal amount of 3.50%...

Evolent Health, Inc. Announces Proposed Offering of $350.0 Million of Convertible Senior Notes Due 2029 to Pay Down Senior Term Loan PR Newswire WASHINGTON, Dec. 5, 2023 WASHINGTON , Dec. 5, 2023 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH) , a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable ("Evolent"), today announced that it intends to offer $350.0 million aggregate principal...

Evolent Announces Third Quarter 2023 Results PR Newswire WASHINGTON, Nov. 2, 2023 WASHINGTON , Nov. 2, 2023 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable, today announced financial results for the quarter ended September 30, 2023. Highlights from the third quarter 2023 announcement include: Revenue of $511.0 million , an increase...

Evolent to release third quarter financial results on Thursday, Nov. 2, 2023, and participate in upcoming investor conferences PR Newswire WASHINGTON, Oct. 10, 2023 WASHINGTON , Oct. 10, 2023 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable, today announced it will release its third quarter 2023 financial results on Thursday, Nov. 2,...

Evolent Health to Participate in Upcoming Conferences PR Newswire WASHINGTON, Aug. 8, 2023 WASHINGTON , Aug. 8, 2023 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable, today announced that Chief Executive Officer Seth Blackley , Chief Financial Officer John Johnson and Vice President, Investor Relations Seth Frank will participate in...

Evolent Announces Second Quarter 2023 Results PR Newswire WASHINGTON, Aug. 2, 2023 WASHINGTON , Aug. 2, 2023 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable, today announced financial results for the quarter ended June 30, 2023 . Highlights from the second quarter 2023 announcement include: Revenue of $469.1 million , an increase of...

Evolent welcomes Toyin Ajayi to its Board of Directors PR Newswire WASHINGTON, July 26, 2023 Dr. Ajayi becomes the ninth independent board member; adds exceptional, relevant expertise as a CEO, physician, entrepreneur and advocate for improving health care quality and cost for underserved populations. WASHINGTON , July 26, 2023 /PRNewswire/ -- Evolent Health Inc. (NYSE: EVH), a health care company that delivers proven value-based specialty care solutions to payers and providers, announced today...

Evolent to Release Second Quarter Financial Results on Wednesday, August 2, 2023 PR Newswire WASHINGTON, July 13, 2023 WASHINGTON , July 13, 2023 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a health care company that delivers proven value-based specialty care solutions to payers and providers, announced today that it will release its second quarter 2023 financial results on Wednesday, August 2, 2023 , after market close, with a conference call to follow at 5 p.m. ET . Shareholders and...

Evolent Health announces focus on value-based specialty care with rebrand, unification of all solutions under "Evolent" PR Newswire WASHINGTON, July 11, 2023 Growth-focused company is a trusted partner for health plans and providers seeking to improve health outcomes across complex conditions. WASHINGTON , July 11, 2023 /PRNewswire/ -- Evolent Health ("the Company") (NYSE: EVH), a health care company that delivers proven value-based specialty care solutions to payers and providers, announced...

Evolent Health to Participate in Upcoming Conferences PR Newswire WASHINGTON, May 9, 2023 WASHINGTON , May 9, 2023 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a health care company that delivers proven clinical and administrative solutions to payers and providers, today announced that Chief Executive Officer Seth Blackley , Chief Financial Officer John Johnson and Vice President, Investor Relations Seth Frank will participate in upcoming investor conferences, including meetings with...

Evolent Health Announces First Quarter 2023 Results PR Newswire WASHINGTON, May 3, 2023 WASHINGTON , May 3, 2023 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a health care company that delivers proven clinical and administrative solutions to payers and providers, today announced financial results for the quarter ended March 31, 2023. Highlights from the first quarter 2023 announcement include: Revenue of $427.7 million , an increase of $130.6 million , or 44.0%, from the three months ended...

Evolent Health Names New Independent Nominee for Election to Board of Directors PR Newswire WASHINGTON, April 19, 2023 Richard Jelinek nominated to join the Board; current director David Farner to depart the Board in June 2023 , in addition to previously announced departure of Frank Williams . WASHINGTON , April 19, 2023 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a health care company that delivers proven specialty clinical solutions to payers and providers, today announced that a new...

Evolent Health to Release First Quarter Financial Results on Wednesday, May 3, 2023 PR Newswire WASHINGTON, April 17, 2023 Company to Also Host an Investor Day on Tuesday, May 23 WASHINGTON , April 17, 2023 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a health care company that delivers proven specialty clinical solutions to payers and providers, today announced it will release its first quarter 2023 financial results on Wednesday, May 3, 2023 , after market close, with a conference call to...

Evolent Health and Centene Agree to Expanded Partnership for Oncology Specialty Care for Medicare Advantage Members PR Newswire WASHINGTON, March 29, 2023 WASHINGTON , March 29, 2023 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a health care company that delivers proven value-based specialty care solutions to payers and providers, today announced an agreement to expand its Technology and Services solution for oncology with its existing partner, Centene Corporation, (NYSE: CNC). Centene will...

Evolent Health to Participate in Upcoming Conferences PR Newswire WASHINGTON, March 3, 2023 WASHINGTON , March 3, 2023 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a health care company that delivers proven clinical and administrative solutions to payers and providers, today announced that Chief Financial Officer John Johnson and Vice President, Investor Relations, Seth Frank will participate in upcoming investor conferences, including meetings with institutional investors and...

Evolent Health Announces Fourth Quarter and Full Year 2022 Results PR Newswire WASHINGTON, Feb. 22, 2023 WASHINGTON , Feb. 22, 2023 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a health care company that delivers proven clinical and administrative solutions to payers and providers, today announced financial results for the quarter ended December 31, 2022. Highlights from the fourth quarter and full year 2022 announcement include: Quarter ended December 31, 2022: Revenue of $382.4 million ,...

Evolent Health, Inc. to Release Fourth Quarter Financial Results and Host Conference Call on Wednesday, February 22, 2023 PR Newswire WASHINGTON, Jan. 31, 2023 WASHINGTON , Jan. 31, 2023 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a health care company that delivers proven clinical and administrative solutions to payers and providers, today announced it will release its fourth quarter 2022 financial results on Wednesday, February 22, 2023 after market close, with a conference call to...